WGN Radio

Ad Scientiam Launches a Pilot Project in the U.S. to Assess MSCopilot®’s Integration into Routine Care for MS Patients

PARIS, FRANCE, February 26, 2025 /EINPresswire.com/ -- Ad Scientiam, a pioneering MedTech company specialized in digital biomarkers, announced today the launch of MS ...
Mena FN

Ad Scientiam Launches U.S. Subsidiary And Expands Deployment Of Mscopilot® Following FDA Registration

(MENAFN- EIN Presswire) EINPresswire/ -- Ad Scientiam, a global leader in digital biomarkers, today announced the creation of its U.S. subsidiary, Ad Scientiam Inc., incorporated in the state of ...
WIVB-TV

Ad Scientiam Launches International Study to Assess Disability Progression in Multiple Sclerosis With MSCopilot

Multiple Sclerosis (MS) is a chronic immune-mediated disease of the central nervous system that affects 2.8 million people worldwide. The disease is characterized by early inflammatory demyelination ...